Antitumor Activity of Tumor‐Infiltrating Neutrophils Revealed by a Syngeneic Mouse Model of Cholangiocarcinoma
Cancer Science · 2025
DOI: 10.1111/cas.70129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Osamu Sugahara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Anticancer Strategies Laboratory, Advanced Research Initiative, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Neutrophils, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The tumor immune microenvironment plays a key role in the regulation of cancer progression. Recent studies have suggested a relation between diverse tumor genotypes and tumor immune microenvironment phenotypes for cholangiocarcinoma (CCA). However, the contribution of tumor‐infiltrating immune cells to CCA progression has remained unclear, underscoring the need for genetically defined CCA models in immunocompetent mice. We here aimed to generate genetically engineered and transplantable CCA organoids from C57BL/6 mice and to investigate the role of tumor‐infiltrating immune cells in CCA progression with this model. CCA organoids were generated ex vivo with the use of the CRISPR/Cas9 system. Orthotopic transplantation of CCA organoids harboring mutations in Smad4 , Trp53 , and Kras into wild‐type C57BL/6 mice resulted in tumor formation accompanied by distant metastasis. Selective depletion of immune cell types in the tumor‐bearing mice revealed an antitumor action of tumor‐infiltrating neutrophils (TINs) that was mediated by direct killing of cancer cells through the production of reactive oxygen species. Furthermore, administration of recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) increased the number and cytotoxicity of TINs, suppressed tumor growth, and prolonged the survival of tumor‐bearing mice. Finally, combination treatment with rhG‐CSF and standard chemotherapy resulted in a synergistic attenuation of tumor growth. Our study therefore provides a syngeneic and genetically defined mouse model of CCA and highlights the therapeutic potential of targeting TINs with rhG‐CSF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anticancer Strategies Laboratory, Advanced Research Initiative, Institute of Science Tokyo, Tokyo, Japan.
- Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
ORCID-Profile: Keiichi I Nakayama
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Sugahara, O., Koga, D., Oka, T., Sugiyama, S., Wada, R., Higa, T., & Nakayama, K. I. (2025). Antitumor Activity of Tumor‐Infiltrating Neutrophils Revealed by a Syngeneic Mouse Model of Cholangiocarcinoma. Cancer Science. https://doi.org/10.1111/cas.70129
Vancouver
Sugahara O, Koga D, Oka T, Sugiyama S, Wada R, Higa T, et al. Antitumor Activity of Tumor‐Infiltrating Neutrophils Revealed by a Syngeneic Mouse Model of Cholangiocarcinoma. Cancer Science. 2025. doi:10.1111/cas.70129
BibTeX
@article{Sugahara2025,
author = {Sugahara, Osamu and Koga, Daisuke and Oka, Takeru and Sugiyama, Shigeaki and Wada, Reona and Higa, Tsunaki and Nakayama, Keiichi I},
title = {Antitumor Activity of Tumor‐Infiltrating Neutrophils Revealed by a Syngeneic Mouse Model of Cholangiocarcinoma},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70129}
}
EUVIMED